R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, vol.68, p.30, 2018.

J. Ferlay, M. Colombet, and I. Soerjomataram, Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, Int J Cancer, vol.144, issue.8, pp.1941-1953, 2019.

A. P. Venook, D. Niedzwiecki, and H. J. Lenz, Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial, JAMA, vol.317, issue.23, pp.2392-2401, 2017.

J. Y. Douillard, S. Siena, and J. Cassidy, Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer, Ann Oncol, vol.25, issue.7, pp.1346-55, 2014.

F. Rivera, M. Karthaus, and J. R. Hecht, Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma, Int J Colorectal Dis, vol.32, issue.8, pp.1179-1190, 2017.

E. Van-cutsem, C. H. Köhne, and E. Hitre, Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer, N Engl J Med, vol.360, pp.1408-1417, 2009.

D. P. Modest, S. Stintzing, V. Weikersthal, and L. F. , Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306), Oncotarget, vol.8, issue.62, pp.105749-105760, 2017.

J. W. Holch, R. I. Stintzing, and S. , The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials, Eur J Cancer, vol.70, pp.87-98, 2017.

D. Arnold, B. Lueza, and J. Y. Douillard, Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials, Ann Oncol, vol.28, issue.8, pp.1713-1729, 2017.

S. Y. Yang, M. S. Cho, and N. K. Kim, Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype, Expert Rev Anticancer Ther, 2018.

B. Baran, M. Ozupek, N. , Y. Tetik, and N. , Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature, Gastroenterology Res, 2018.

M. C. Merlano, C. Granetto, and E. Fea, Heterogeneity of colon cancer: from bench to bedside. ESMO Open, vol.2, p.218, 2017.

A. P. Venook, F. Ou, and H. Lenz, Primary tumor location as an independent prognostic marker from molecular features for overall survival in patients with metastatic colorectal cancer: Analysis of CALGB/SWOG 80405, ASCO Annual Meeting. Abstract 3503. Presented, 2017.

S. C. Kamran, J. W. Clark, and H. Zheng, Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis, Cancer Med, 2018.

J. M. Weiss, P. R. Pfau, and O. Es, Mortality by stage for right versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-medicare data, J Clin Oncol, vol.29, issue.33, pp.4401-4410, 2011.

S. Ishihara, T. Nishikawa, and T. Tanaka, Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study, Int J Surg, vol.12, issue.9, pp.925-955, 2014.

P. Snaebjornsson, L. Jonasson, and T. Jonsson, Colon cancer in Icelande a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age, Int Journal Cancer Journal international du cancer, vol.127, pp.2645-53, 2010.

T. J. Price, C. Beeke, and S. Ullah, Does the primary site of colorectal cancer impact outcomes of patients with metastatic disease? Cancer, vol.121, pp.830-835, 2015.

E. Viadana, . Bross, . Id, and J. W. Pickren, The metastatic spread of cancers of the digestive system in man, Oncology, vol.35, issue.3, pp.114-140, 1978.

M. Riihimaki, A. Hemminki, and J. Sundquist, Patterns of metastasis in colon and rectal cancer. Sci Rep, vol.6, p.29765, 2016.

S. Mendis, S. Beck, and B. Lee, Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival, Asia Pac J Clin Oncol, 2019.

J. Engstrand, H. Nilsson, and C. Strömberg, Colorectal cancer liver metastases -a population-based study on incidence, management and survival, BMC Cancer, vol.18, p.78, 2018.

V. E. Lemmens, Y. L. Klaver, and V. J. Verwaal, Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study, Int J Cancer, 2011.

, Jun, vol.1, issue.11, pp.2717-2742

M. H. Jang, S. Kim, and D. Y. Hwang, BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status, J Korean Med Sci, vol.32, issue.1, pp.38-46, 2017.

C. E. Atreya, C. Greene, and R. M. Mcwhirter, Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location, J Natl Compr Canc Netw, vol.14, issue.12, pp.1536-1543, 2016.

J. Guinney, R. Dienstmann, and X. Wang, The consensus molecular subtypes of colorectal cancer, Nat Med, vol.21, pp.1350-1356, 2015.

D. Luo, Q. Liu, and W. Yu, Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study, Int J Colorectal Dis, 2018.

J. Franko, Q. Shi, and J. P. Meyers, Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from Analysis and Research in Cancers of the Digestive System (ARCAD) database, Lancet Oncol, vol.17, issue.12, pp.1709-1719, 2016.

M. E. Salem, B. A. Weinberg, and J. Xiu, Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers, Oncotarget, vol.8, issue.49, pp.86356-86368, 2017.

M. Inoue, M. Ohta, and K. Iuchi, Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma, Ann Thorac Surg, vol.78, issue.1, pp.238-282, 2004.

J. S. Tomlinson, W. R. Jarnagin, and R. P. Dematteo, Actual 10 year survival after resection of colorectal liver metastases defines cure, J Clin Oncol, vol.25, pp.4575-80, 2007.

D. Jong, M. C. Pulitano, C. Ribero, and D. , Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients, Ann Surg, vol.250, pp.440-448, 2009.

B. J. Robinson, T. W. Rice, and S. A. Strong, Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?, J Thorac Cardiovasc Surg, vol.117, pp.66-75, 1999.

. Benson, A. P. Venook, and A. Mm, NCCN Guidelines Insights: Colon Cancer, Version 2, J Natl Compr Canc Netw, vol.16, issue.4, pp.359-369, 2018.

H. J. Schmoll, E. Van-cutsem, and A. Stein, ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making, Ann Oncol, vol.23, issue.10, pp.2479-516, 2012.

F. Ghiringhelli, D. Bichard, and S. Limat, Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection, Ann Surg Oncol, vol.21, issue.5, pp.1632-1672, 2014.

M. Cabart, J. S. Frenel, and L. Campion, Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study, Clin Colorectal Cancer, vol.15, issue.4, pp.165-174, 2016.

C. Lim, A. Doussot, and M. Osseis, Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first, Clin Transl Oncol, vol.20, issue.10, pp.1274-1279, 2018.

A. Abajo, N. Bitarte, and R. Zarate, Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array, World J Gastroenterol, vol.18, pp.637-682, 2012.

Y. W. Kim, Y. T. Ko, and N. K. Kim, A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis, Scand J Gastroenterol, vol.45, pp.217-242, 2010.

S. Mendis, S. Beck, and B. Lee, Left versus right side metastatic colorectal cancer. Teasing out clinicopathologic drivers of disparity in survival, 2019.